Enzymatic breakthrough enables precise control of cannabinoid modification

Researchers have developed a new enzymatic method for chemically modifying cannabinoids from cannabis through a process called bromination. Using an enzyme called CiVCPO in micellar solutions, scientists achieved selective dibromination of cannabinoids with yields up to 72% for CBN and 67% for CBL, significantly improving upon conventional chemical methods. The key advantage of this enzymatic approach is its ability to avoid unwanted side reactions and overoxidation that typically occur with traditional chemical methods, while maintaining high substrate conversion rates.

What makes this breakthrough particularly valuable is the level of control it provides. By adjusting the enzyme concentration between 300-500 nanomolar, researchers can fine-tune the bromination process to produce either mono- or dibrominated products on demand. This precision addresses a major challenge in modifying natural products—most conventional methods either produce unwanted byproducts or require harsh conditions that damage sensitive molecules.

The broader significance of this work lies in its demonstration of how enzymatic catalysis can serve as a mild, selective platform for creating novel cannabinoid derivatives. These brominated cannabinoids could potentially exhibit different biological properties than their parent compounds, opening new avenues for drug development and research into cannabinoid mechanisms. By offering a superior alternative to conventional chemical methods, this enzymatic strategy provides a foundation for developing improved cannabis-derived therapeutics with fewer manufacturing complications and higher purity.